|
WO2006037993A2
|
|
Cancer markers
|
|
GB0421914D0
|
|
Drug metabolising enzyme in cancer
|
|
GB0421913D0
|
|
Tumour-specific pro drug target
|
|
GB0421919D0
|
|
Cytochrome P450 prodrug target
|
|
EP2295976A1
|
|
Markers for colorectal cancer
|
|
GB0305350D0
|
|
Potential cell cycle protein and cancer
|
|
GB0305345D0
|
|
Protein marker of cancer with multiple binding partners
|
|
GB0305385D0
|
|
Protein processing factor and cancer
|
|
GB0305387D0
|
|
Protein stability and cancer
|
|
GB0305382D0
|
|
Purine synthesis protein and cancer
|
|
GB0305353D0
|
|
Apoptosis-related protein and cancer
|
|
GB0305351D0
|
|
Oligonucleotide binding protein in cancer
|
|
GB0305342D0
|
|
Protein folding in cancer
|
|
GB0305346D0
|
|
Chromatin-associated protein and cancer
|
|
GB0305347D0
|
|
Protein with multiple interactions
|
|
GB0305348D0
|
|
Membrane-associated protein in cancer
|
